|
⚲
|
| Keyboard |
| Loesberg Janet
✚
|
|
|---|---|
| CIK # | 0001956550 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001956550] | |
| 4 | [0001956550] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Ambrx Biopharma Inc | |
| Loesberg Janet | |
| Ambrx Biopharma Cayman Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Ambrx Biopharma Inc AMAM
Option to Purchase Common Stock · derivative
|
2024-03-07 | Disposed to issuer | 30,000 | ||
|
Ambrx Biopharma Inc AMAM
Option to Purchase Common Stock · derivative
|
2024-03-07 | Disposed to issuer | 15,000 | ||
|
Ambrx Biopharma Inc AMAM
Restricted Stock Units · derivative
|
2024-03-07 | Disposed to issuer | 12,142 | ||
|
Ambrx Biopharma Cayman Inc AMAM
Ordinary Shares
|
2023-06-07 | Grant | 85,000 | $0.00 | |
|
Ambrx Biopharma Cayman Inc AMAM
Stock Option (right to buy) · derivative
|
2023-01-27 | Grant | 105,000 | ||
|
Ambrx Biopharma Cayman Inc AMAM
Stock Option (right to buy) · derivative
|
2023-01-27 | Grant | 210,000 | ||
|
Ambrx Biopharma Cayman Inc AMAM
Stock Option (right to buy) · derivative
|
2023-01-27 | Disposed to issuer | 210,000 | ||
|
Ambrx Biopharma Cayman Inc AMAM
Stock Option (right to buy) · derivative
|
2023-01-27 | Disposed to issuer | 105,000 |